The central question revolves around whether the former President secured a specific, lower price for a medication vital for individuals managing diabetes. Specifically, the focus is on insulin, a hormone essential for regulating blood sugar levels, and whether a significant price reduction to $35 per prescription was achieved under his administration.
Access to affordable insulin is crucial for the health and well-being of millions. High insulin costs have historically forced many to ration their doses, leading to severe health consequences. Therefore, any efforts to lower the price of this life-saving medication are significant, and the historical context of such efforts by past administrations is important to consider.
